(ROIV) - Analyst Ratings

(ROIV) – Analyst Ratings

Apr 3, 2024 06:44 AM Roivant Sciences (ROIV) PT Raised to $18 at H.C. Wainwright, 'brepocitinib has blockbuster potential'
Apr 2, 2024 03:55 PM Roivant Sciences (ROIV) PT Raised to $18 at Goldman Sachs
Apr 2, 2024 08:08 AM
Apr 2, 2024 08:04 AM
Mar 21, 2024 09:32 AM
Mar 13, 2024 05:30 AM
Feb 15, 2024 03:43 PM
Feb 15, 2024 04:51 AM
Jan 5, 2024 03:55 AM
Dec 11, 2023 04:08 PM
Oct 17, 2023 06:12 AM
Sep 26, 2023 06:47 AM
Jun 23, 2023 07:37 AM
Jun 8, 2023 06:02 AM
Mar 15, 2023 01:02 PM
Jan 4, 2023 11:33 AM
Jan 4, 2023 09:36 AM
Jan 4, 2023 09:35 AM
Sep 26, 2022 04:11 PM
Jun 28, 2022 04:41 PM
May 25, 2022 05:59 AM
May 24, 2022 08:21 AM
May 23, 2022 03:45 AM
Apr 29, 2022 05:52 AM
Mar 23, 2022 10:43 AM
Feb 15, 2022 05:58 AM
Dec 15, 2021 04:43 AM
Nov 8, 2021 06:12 AM
Oct 28, 2021 06:17 AM
Oct 26, 2021 08:47 AM
Oct 26, 2021 07:38 AM
Oct 26, 2021 06:09 AM
Oct 26, 2021 05:38 AM